OBJECTIVES: Baseline brain single-photon emission computed tomography (SPECT) can predict mild cognitive impairment (MCI) patients at risk for progressive MCI (PMCI). METHODS: Twenty-eight subjects [12 MCI, 6 with probable Alzheimer's Disease (AD), and 10 normal subjects] underwent baseline brain SPECT and were clinically followed for a mean period of 36 months. RESULTS: Of 12 MCI patients, 6 progressed to PMCI and 6 remained stable. Baseline SPECT identified asymmetric perfusion reduction in the parahippocampus (-5%), lateral parietal (-8%), and posterior cingulate (-11%) cortices--reductions consistent with that of mild AD--in five of the six PMCI patients. Significant perfusion reduction was observed particularly in the frontal cortices of probable AD when compared with PMCI (P < 0.05). CONCLUSION: Baseline SPECT can identify brain perfusion abnormalities among patients with MCI for progression to PMCI. This imaging modality may aid in MCI treatment stratification.
OBJECTIVES: Baseline brain single-photon emission computed tomography (SPECT) can predict mild cognitive impairment (MCI) patients at risk for progressive MCI (PMCI). METHODS: Twenty-eight subjects [12 MCI, 6 with probable Alzheimer's Disease (AD), and 10 normal subjects] underwent baseline brain SPECT and were clinically followed for a mean period of 36 months. RESULTS: Of 12 MCI patients, 6 progressed to PMCI and 6 remained stable. Baseline SPECT identified asymmetric perfusion reduction in the parahippocampus (-5%), lateral parietal (-8%), and posterior cingulate (-11%) cortices--reductions consistent with that of mild AD--in five of the six PMCI patients. Significant perfusion reduction was observed particularly in the frontal cortices of probable AD when compared with PMCI (P < 0.05). CONCLUSION: Baseline SPECT can identify brain perfusion abnormalities among patients with MCI for progression to PMCI. This imaging modality may aid in MCI treatment stratification.
Authors: Linda L Chao; Shannon T Buckley; John Kornak; Norbert Schuff; Catherine Madison; Kristine Yaffe; Bruce L Miller; Joel H Kramer; Michael W Weiner Journal: Alzheimer Dis Assoc Disord Date: 2010 Jan-Mar Impact factor: 2.703
Authors: A Caroli; C Testa; C Geroldi; F Nobili; L R Barnden; U P Guerra; M Bonetti; G B Frisoni Journal: J Neurol Date: 2007-11-09 Impact factor: 4.849
Authors: Flavio Nobili; Giovanni B Frisoni; Florence Portet; Frans Verhey; Guido Rodriguez; Anna Caroli; Jacques Touchon; Piero Calvini; Silvia Morbelli; Fabrizio De Carli; Ugo P Guerra; Laura A Van de Pol; Pieter-Jelle Visser Journal: J Neurol Date: 2008-08-01 Impact factor: 4.849
Authors: Seth D Friedman; Laura D Baker; Soo Borson; J Eric Jensen; Suzanne M Barsness; Suzanne Craft; George R Merriam; Randolph K Otto; Edward J Novotny; Michael V Vitiello Journal: JAMA Neurol Date: 2013-07 Impact factor: 18.302
Authors: Adam S Fleisher; Katherine M Podraza; Katherine J Bangen; Curtis Taylor; Ayesha Sherzai; Kunal Sidhar; Thomas T Liu; Anders M Dale; Richard B Buxton Journal: Neurobiol Aging Date: 2008-03-05 Impact factor: 4.673
Authors: Ai-Ling Lin; Ethan Poteet; Fang Du; Roy C Gourav; Ran Liu; Yi Wen; Andrew Bresnen; Shiliang Huang; Peter T Fox; Shao-Hua Yang; Timothy Q Duong Journal: PLoS One Date: 2012-10-09 Impact factor: 3.240
Authors: A M Tiehuis; K L Vincken; E van den Berg; J Hendrikse; S M Manschot; W P T M Mali; L J Kappelle; G J Biessels Journal: Diabetologia Date: 2008-05-17 Impact factor: 10.122